$SLXP Company News Drug companies Salix, Intercept

New Post Public Reply Private Reply Replies (0) Message Board

Nov 9, 2014 at 12:19 PM

$SLXP Company News

Drug companies Salix, Intercept reeling after earnings, drama 12:15 p.m. Nov. 7, 2014 - Russ Britt
Ackman urges Allergan to open sale process, negotiate 10:33 a.m. Nov. 7, 2014 - Chelsey Dulaney
Sears leaps on REIT talk; First Solar drops on weak results 10:15 a.m. Nov. 7, 2014 - Sue Chang
Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop 8:45 a.m. Nov. 7, 2014 - Shawn Langlois
Disney’s stock slides as quarterly earnings lack magic 7:04 p.m. Nov. 6, 2014 - Sue Chang
Salix Pharma shares fall on disappointing outlook, CFO resignation 6:54 p.m. Nov. 6, 2014 - Wallace Witkowski
Scuttled ‘inversion’ deals pile up in wake of Treasury rules 3:14 p.m. Oct. 27, 2014 - Robert Schroeder
In focus: Volatility ramps up 5:35 p.m. Oct. 8, 2014 - Lawrence G. McMillan
RadioShack gets a jolt from financing report; Mylan rises 8:22 a.m. Oct. 3, 2014 - Sue Chang
Salix shares jump 5.9% premarket as merger plan is cancelled 7:14 a.m. Oct. 3, 2014 - Silvia Ascarelli
What could scare markets over upcoming earnings, and Buffett’s onto something 6:09 a.m. Oct. 3, 2014 - Barbara Kollmeyer
Salix, Cosmo cancel merger amid inversion crackdown 3:44 a.m. Oct. 3, 2014 - Chip Cummins
Pharma love triangle is a win, win, win for investors 1:11 p.m. Oct. 2, 2014 - The Trading Deck
T. Rowe Price urges Allergan to drop Salix bid 3:38 p.m. Sept. 26, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:51 a.m. Sept. 24, 2014 - Russ Britt
Actavis's Salix play undermines Allergan defense 11:43 a.m. Sept. 24, 2014 - Russ Britt
Actavis reportedly in talks to buy Salix Pharma 11:42 a.m. Sept. 24, 2014 - Russ Britt
Pershing threatens to sue Allergan if no holder vote held on Salix deal 8:28 a.m. Sept. 23, 2014 - David Benoit
Botox maker Allergan rejected Actavis takeover bid 6:18 p.m. Sept. 22, 2014 - Jonathan D. Rockoff
In focus: Market giving mixed signals 7:02 p.m. Sept. 17, 2014 - Lawrence G. McMillan

'Fast Money' Recap: When Is the Best Time to Buy Twitter Stock? 5:00 a.m. Nov. 8, 2014 - TheStreet.com
Health Sell-Offs Drag On IBD 50 6:31 p.m. Nov. 7, 2014 - Investors Business Daily
Market News: Sears, Salix Pharmaceuticals, Walt Disney 4:38 p.m. Nov. 7, 2014 - TheStreet.com
Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data 4:22 p.m. Nov. 7, 2014 - TheStreet.com
Ackman Calls for Auction of Allergan 3:38 p.m. Nov. 7, 2014 - The Wall Street Journal Interactive Edition
Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour 3:19 p.m. Nov. 7, 2014 - TheStreet.com
Stock Movers: Why Medicals Issues Are Dipping Today 2:26 p.m. Nov. 7, 2014 - Investors Business Daily
Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, Intercept Pharmaceuticals, Extended Stay America 12:38 p.m. Nov. 7, 2014 - benzinga.com
Salix Pharmaceuticals (SLXP) Earnings Report: Q3 2014 Conference Call Transcript 11:30 a.m. Nov. 7, 2014 - TheStreet.com
Salix Q3 Earnings Marred by Inventory Issues, Cuts View - Analyst Blog 11:09 a.m. Nov. 7, 2014 - Zacks.com
Cramer: Salix Pharmaceuticals' Audit Committee Review Is Concerning 10:54 a.m. Nov. 7, 2014 - TheStreet.com
Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being Even More Likely Now 9:39 a.m. Nov. 7, 2014 - benzinga.com
Benzinga's Top Downgrades 8:56 a.m. Nov. 7, 2014 - benzinga.com
It's going to be ugly for Salix today 8:38 a.m. Nov. 7, 2014 - Seeking Alpha
Today's Pre-Market Mover With Heavy Volume: Salix Pharmaceuticals (SLXP) 7:54 a.m. Nov. 7, 2014 - TheStreet.com
Stifel Nicolaus Downgrades Salix Pharmaceuticals To Hold 7:44 a.m. Nov. 7, 2014 - benzinga.com
Benzinga's Top #PreMarket Losers 7:22 a.m. Nov. 7, 2014 - benzinga.com
UPDATE: Stifel Downgrades Salix Pharmaceuticals As Uncovered Inventories Leaves Many Open Questions 7:15 a.m. Nov. 7, 2014 - benzinga.com
Wall Street Breakfast: Home Depot Says 53M Emails Stolen During Breach 6:30 a.m. Nov. 7, 2014 - Seeking Alpha
10-Q: SALIX PHARMACEUTICALS LTD 6:23 a.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)

Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Salix Pharmaceuticals, Ltd. (SLXP) 11:12 p.m. Nov. 7, 2014 - GlobeNewswire
SALIX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates Salix Pharmaceuticals Ltd. Following Disclosure of Disappointing Third Quarter Results and Resignation of CFO 10:00 p.m. Nov. 7, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of Salix Pharmaceuticals Ltd. 8:10 p.m. Nov. 7, 2014 - PR Newswire - PRF
Federman & Sherwood Investigates Salix Pharmaceuticals, Ltd. for Possible Violations of Federal Securities Laws 5:23 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Investigation on Behalf of Salix Pharmaceuticals, Ltd. Investors Announced by Law Offices of Howard G. Smith 3:32 p.m. Nov. 7, 2014 - BusinessWire - BZX
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Salix Pharmaceuticals Ltd. - SLXP 3:10 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Salix Pharmaceuticals, Ltd. 2:02 p.m. Nov. 7, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Salix Pharmaceuticals Ltd. 1:01 p.m. Nov. 7, 2014 - PR Newswire - PRF
Salix Pharmaceuticals Ltd. Investigated by Block & Leviton LLP After The Company Announces Resignation Of Its Chief Financial Officer And Reduced Financial Forecasts 11:09 a.m. Nov. 7, 2014 - PR Newswire - PRF
Recover Losses: Ademi & O'Reilly, LLP Investigates Possible Securities Fraud of Salix Pharmaceuticals, Ltd. 10:08 a.m. Nov. 7, 2014 - GlobeNewswire
SALIX SHAREHOLDER ALERT: Investor Rights Firm Johnson & Weaver, LLP Announces Investigation of Salix Pharmaceuticals Ltd. 7:20 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Reports 3Q2014 Results 4:14 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Appoints Acting Chief Financial Officer 4:04 p.m. Nov. 6, 2014 - BusinessWire - BZX
Salix and Pharming Announce the Launch of RUCONEST® in the U.S. for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE) 1:00 a.m. Nov. 3, 2014 - BusinessWire - BZX
Fitch: M&A Premiums Fall on Inversion Crackdown 9:10 a.m. Oct. 27, 2014 - BusinessWire - BZX
Salix Pharmaceuticals Announces 3Q2014 Financial Results Conference Call and Webcast 7:01 a.m. Oct. 23, 2014 - BusinessWire - BZX
New Medicare Plan, Clinical Study Results, ANDA Filing Confirmation, Strategic Collaboration, and Merger Termination - Research Reports on UnitedHealth, Celgene, Actavis, Bristol-Myers Squibb and Salix 9:10 a.m. Oct. 22, 2014 - PR Newswire - PRF
Salix’s TARGET 3 Study Examines the Safety and Efficacy of Repeat Treatment with Rifaximin 550 mg for Irritable Bowel Syndrome with Diarrhea 7:01 a.m. Oct. 21, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis 8:31 a.m. Oct. 8, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bertram Capital Backs MCE's Expansive Growth Vision

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

D-Wave Investors Must Decide by Dec 15 Class Suit

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

AVANT BIO Beef Up Team with Heavyweights Lio, Vanek

AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...

Massive $1B Jobs Initiative Fights AI Automation Impact

Initiative Tackles Economic Shifts Head-On AI and automation are turning the job market upside down, and more than 20 foundations and philanthropies are throwing their weight behind a $1 billion initiative called All In For Jobs. Their aim? Connect half a million Americans to stable, decent-paying jobs and prepare communities to face the daunting transition imposed by...

Natural Field Reinvents Supplement Delivery at SupplySide

Pioneering New Frontiers in Supplement Delivery Sometimes you can taste the winds of change in your morning coffee, and this time it’s in the world of dietary supplements. SupplySide Global 2026 is shaking up the scene, folks, and Natural Field Co., Ltd. is leading that charge with some pioneering approaches that might just redefine how we gulp our health aids. Beyond...

Touchmark's Q3 Bonanza: Income Leaps 39%, Stock Repurchase

Ever seen a bank juggle financials like a street performer with flaming torches? That's Touchmark Bancshares for you this quarter. This Georgia-based community bank just released their third quarter 2026 results, and it seems they've not only mastered performance but also pranced around market risks effortlessly, much to the delight of investors. Breaking Down the Numbers...

Parloa's AI Agents Boost SAP Customer Experience

AI Meets SAP in Customer Experience Revolution Alright, let's cut through the tech chatter. Parloa’s Agent Management Platform has hitched its wagon to SAP as a spiffy Solution Extension. This isn't just tech fluff—it’s a big step for scratching that CX itch companies have. By merging Parloa's AI magic with SAP's existing mojo, businesses get a toolset to enhance...

Innventure Faces Legal Scrutiny Over DarkNX Debacle

Innventure’s Market Tumult: Unraveling the Drama Talk about a mess. Innventure Inc. (NASDAQ: INV) investors are likely feeling a sting sharper than a bee that's lost its hive after a painful 55% stock crash back in August 2026. The culprit? A scuttled project involving a shadowy partner, DarkNX, and a lot of questions about who knew what and when. A Puzzling...

GrOwnValve's Personalized Valves Pass Safety Milestone

Pioneering Success in Personalized Valve Study GrOwnValve GmbH just hit a big milestone that's caught my attention. Their first-in-human heart valve study wrapped up its six-month run with no prosthesis-related mishaps. Yeah, zero misfires. For five whole patients who've been through the wringer, things held steady. This Berlin startup’s got guts, testing tech that...

Fair Play in Focus: SYNA, CSR, VCTR, EFSI Deals Scrutinized

The Corporate Buzz: Deals Under the Microscope Riding the rollercoaster of mergers and acquisitions ain't new in the stock market realm. But when the stakes seem one-sided, alarms start ringing. Halper Sadeh LLC, a firm that cuts its teeth on this kind of corporate sleuthing, is all hands on deck probing a slew of big deals involving Synaptics (NASDAQ:SYNA), Centerspace...